Menu
Back to Journals » Journal of Asthma and Allergy » Volume 11
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Authors Ashkenazi M , Sity S , Sarouk I, Bar Aluma BE, Dagan A, Bezalel Y, Bentur L, De Boeck K, Efrati O
Received 13 July 2018
Accepted for publication 13 July 2018
Published 13 September 2018 Volume 2018:11 Pages 245—246
Ashkenazi M, Sity S, Sarouk I, et al. J Asthma Allergy. 2018;11:101–107.
On page 101, in the Conclusion section, the text “omlaizumb” should have been “omalizumab”.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.